Aonong Biotech announced that the concerted action agreement signed by the company's shareholders China Foreign Trade Trust Co., Ltd. - Foreign Trade Trust - Xuanwu No. 13 Pooled Fund Trust Plan, Xiamen International Trust Co., Ltd. - Xiamen Trust - Aochuangzhi, and Beijing Yawen Chunya Technology Development Center expired and terminated on December 27, 2025, and the concerted action relationship was terminated. Prior to the change in equity, the three parties held a total of 208 million shares of the company, accounting for 7.9829% of the company's total share capital. After the change in equity, the three parties' shareholding ratios were 2.4972%, 4.7254%, and 0.7684%, respectively, and none of them were shareholders holding 5% or more of the company's shares.

Aonong Biotech announced that the concerted action agreement signed by the company's shareholders China Foreign Trade Trust Co., Ltd. - Foreign Trade Trust - Xuanwu No. 13 Pooled Fund Trust Plan, Xiamen International Trust Co., Ltd. - Xiamen Trust - Aochuangzhi, and Beijing Yawen Chunya Technology Development Center expired and terminated on December 27, 2025, and the concerted action relationship was terminated. Prior to the change in equity, the three parties held a total of 208 million shares of the company, accounting for 7.9829% of the company's total share capital. After the change in equity, the three parties' shareholding ratios were 2.4972%, 4.7254%, and 0.7684%, respectively, and none of them were shareholders holding 5% or more of the company's shares.